Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Rebecca Heist, including the following topics: Targeting MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) (0:00) Efficacy and tolerability of MET tyrosine kinase inhibitors in patients with NSCLC and MET alterations (12:35) Mechanisms of resistance to therapies for MET-altered NSCLC (19:11) Evaluating the role of antibody-based therapy in the treatment of MET-altered NSCLC  (25:17) CME information and select publications